Jakob Begun

9.1k total citations · 1 hit paper
106 papers, 3.9k citations indexed

About

Jakob Begun is a scholar working on Genetics, Epidemiology and Molecular Biology. According to data from OpenAlex, Jakob Begun has authored 106 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Genetics, 34 papers in Epidemiology and 31 papers in Molecular Biology. Recurrent topics in Jakob Begun's work include Inflammatory Bowel Disease (38 papers), Microscopic Colitis (26 papers) and Gastrointestinal motility and disorders (10 papers). Jakob Begun is often cited by papers focused on Inflammatory Bowel Disease (38 papers), Microscopic Colitis (26 papers) and Gastrointestinal motility and disorders (10 papers). Jakob Begun collaborates with scholars based in Australia, United States and United Kingdom. Jakob Begun's co-authors include Frederick M. Ausubel, Costi D. Sifri, Stephen B. Calderwood, Gary Ruvkun, Danielle A. Garsin, Dennis H. Kim, Ramnik J. Xavier, Páraic Ó Cuív, Timothy H. Florin and Michael A. McGuckin and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Jakob Begun

97 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Upadacitinib Induction and Maintenance Therapy for Crohn’s Disease

2023 218 citations Édouard Louis, Jakob Begun et al. profile →

Peers

Countries citing papers authored by Jakob Begun

Since Specialization

Citations

This map shows the geographic impact of Jakob Begun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jakob Begun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jakob Begun more than expected).

Fields of papers citing papers by Jakob Begun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jakob Begun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jakob Begun. The network helps show where Jakob Begun may publish in the future.

Co-authorship network of co-authors of Jakob Begun

This figure shows the co-authorship network connecting the top 25 collaborators of Jakob Begun. A scholar is included among the top collaborators of Jakob Begun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jakob Begun. Jakob Begun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Proinflammatory macrophages transporting gut-derived bacterial DNA drive autoimmune arthritis in spondyloarthropathy 2025 ·JCI Insight ·(unknown), Rabina Giri, (unknown), (unknown), (unknown), Christopher Altmann, Yenkai Lim, Linda M. Rehaume, Mark Morrison, Mihir D. Wechalekar, Jakob Begun, Anne‐Sophie Bergot, Ranjeny Thomas	0
2	Editorial: Intestinal Ultrasound for the Assessment of Constipation—Out of the Shadows? Authors' Reply 2025 ·Alimentary Pharmacology & Therapeutics ·(unknown), Thomas M Goodsall, Claire E. Parker, Alice S. Day, (unknown), (unknown), Chamara Basnayake, Jakob Begun, Ray Boyapati, Rebecca Burgell, Michael T. Dolinger, Giovanni Maconi, Kerri L. Novak, Shintaro Sagami, Rebecca L. Smith, Ashish Srinivasan, Stuart A. Taylor, Vipul Jairath, Christopher Ma, Robert V. Bryant	0
3	Upadacitinib and vedolizumab combination therapy for the management of refractory ulcerative colitis and Crohn’s disease 2025 ·Intestinal Research ·(unknown), (unknown), (unknown), (unknown), Yoon‐Kyo An, Jakob Begun	1
4	Colon‐targeted complement C5a₁ receptor inhibition using pH‐sensitive nanoparticles ameliorates experimental colitis 2025 ·British Journal of Pharmacology ·(unknown), (unknown), Xaria X. Li, Rabina Giri, (unknown), Vinod Kumar, Andrew K. Whittaker, Felicity Y. Han, Richard J. Clark, Jakob Begun, John D. Lee, Trent M. Woodruff	2
5	Expert Position Statement: Defining the Role of Intestinal Ultrasound in Assessing Constipation and Faecal Loading 2025 ·Alimentary Pharmacology & Therapeutics ·(unknown), Thomas M Goodsall, Claire E. Parker, Alice S. Day, Yoon‐Kyo An, (unknown), Chamara Basnayake, Jakob Begun, Ray Boyapati, Rebecca Burgell, Michael T. Dolinger, Giovanni Maconi, Kerri L. Novak, Shintaro Sagami, Rebecca L. Smith, Ashish Srinivasan, Stuart A. Taylor, Vipul Jairath, Christopher Ma, Robert V. Bryant	2
6	Impact of a Patient Support Program on time to discontinuation of adalimumab in Australian adult patients with immune-mediated inflammatory diseases–an observational study 2024 ·PLoS ONE ·Graeme Jones, Miriam Calao, Jakob Begun, (unknown), (unknown), (unknown), Pablo Fernández‐Peñas, Alan B. Watts, Andrew J.K. Östör	0
7	Comprehensive systematic review and pooled analysis of real‐world studies evaluating immunomodulator and biologic therapies for chronic pouchitis treatment 2023 ·JGH Open ·(unknown), Andrew Lee, Teresa Neeman, Yoon‐Kyo An, Jakob Begun	1
8	P614 Reduction of bowel wall thickness and doppler signals as early as 36 hours predicts corticosteroid response in a multi-centre prospective cohort of Acute Severe Ulcerative Colitis: USUC Study including the GENIUS cohort 2023 ·Journal of Crohn s and Colitis ·Yoon‐Kyo An, (unknown), (unknown), (unknown), (unknown), (unknown), Lena Thin, (unknown), (unknown), Emily K. Wright, Roy E. Smith, Antony B. Friedman, Jakob Begun, (unknown)	1
9	Upadacitinib Salvage Therapy for Infliximab-Experienced Patients with Acute Severe Ulcerative Colitis 2023 ·Journal of Crohn s and Colitis ·(unknown), (unknown), (unknown), Yoon‐Kyo An, Jakob Begun	35
10	An Extremes of Phenotype Approach Confirms Significant Genetic Heterogeneity in Patients with Ulcerative Colitis 2022 ·Journal of Crohn s and Colitis ·Sally Mortlock, Anton Lord, Grant W. Montgomery, Martha Zakrzewski, Lisa A. Simms, Krupa Krishnaprasad, Katherine Hanigan, James D. Doecke, Alissa Walsh, Ian C. Lawrance, Peter A. Bampton, Jane M. Andrews, Gillian Mahy, Susan J. Connor, Miles Sparrow, Sally Bell, Timothy H. Florin, Jakob Begun, Richard B. Gearry, Graham Radford‐Smith	5
11	The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis 2022 ·Intestinal Research ·Jae Hee Cheon, Kristine Paridaens, Sameer Al Awadhi, Jakob Begun, John Fullarton, Édouard Louis, Fernando Magro, Juan Ricardo Márquez, Alexander R. Moschen, Neeraj Narula, Grażyna Rydzewska, Axel Dignaß, Simon Travis	1
12	Expression of CD49f defines subsets of human regulatory T cells with divergent transcriptional landscape and function that correlate with ulcerative colitis disease activity 2021 ·Clinical & Translational Immunology ·(unknown), Jasmin Straube, Katie E. Lineburg, Leanne Cooper, Steven Lane, Corey Smith, (unknown), Jakob Begun, John J. Miles, Michelle M. Hill, Ailin Lepletier	4
13	Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis 2021 ·Scandinavian Journal of Gastroenterology ·Axel Dignaß, Kristine Paridaens, Sameer Al Awadhi, Jakob Begun, Jae Hee Cheon, John Fullarton, Édouard Louis, Fernando Magro, Juan Ricardo Márquez, Alexander R. Moschen, Neeraj Narula, Grażyna Rydzewska, Simon Travis	5
14	IgM and IgA augmented autoantibody signatures improve early‐stage detection of colorectal cancer prior to nodal and distant spread 2021 ·Clinical & Translational Immunology ·(unknown), (unknown), Yonghua Sheng, Karen Lawler, Christopher Schmidt, Nam‐Trung Nguyen, Jakob Begun, Gregor Kijanka	13
15	Distinct Tissue-Specific Roles for the Disease-Associated Autophagy Genes ATG16L2 and ATG16L1 2019 ·The Journal of Immunology ·Bernard Khor, Kara L. Conway, (unknown), Moshe Biton, Adam L. Haber, Noga Rogel, Leigh A. Baxt, Jakob Begun, Petric Kuballa, John D Gagnon, Kara G. Lassen, Aviv Regev, Ramnik J. Xavier	19
16	Gastrointestinal ultrasound in inflammatory bowel disease care: Patient perceptions and impact on disease‐related knowledge 2019 ·SHILAP Revista de lepidopterología ·(unknown), Dharshan Sathananthan, Yoon‐Kyo An, (unknown), (unknown), (unknown), Samuel P. Costello, Jakob Begun, Robert V. Bryant	42
17	The gut bacterium and pathobiont Bacteroides vulgatus activates NF-κB in a human gut epithelial cell line in a strain and growth phase dependent manner 2017 ·Anaerobe ·Páraic Ó Cuív, Tomás de Wouters, Rabina Giri, Stanislas Mondot, Wendy Smith, Hervé M. Blottière, Jakob Begun, Mark Morrison	61
18	The incidence of 30-day adverse events after colonoscopy in an IBD population 2016 ·Queensland's institutional digital repository (The University of Queensland) ·(unknown), Jennifer A. Wong, (unknown), (unknown), David G. Hewett, Mark Appleyard, Jakob Begun	1
19	High fat diets induce colonic epithelial cell stress and inflammation that is reversed by IL-22 2016 ·Queensland's institutional digital repository (The University of Queensland) ·(unknown), Rohan Lourie, Hui Tong, (unknown), V Schreiber, Graham Magor, Stuart E. Denman, Jakob Begun, Timothy H. Florin, Amy E. Perkins, Páraic Ó Cuív, Michael A. McGuckin, Sumaira Z. Hasnain	1
20	Long-Lived C. elegans daf-2 Mutants Are Resistant to Bacterial Pathogens 2003 ·Science ·Danielle A. Garsin, (unknown), Jakob Begun, Dennis H. Kim, Costi D. Sifri, Stephen B. Calderwood, Gary Ruvkun, Frederick M. Ausubel	465

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact